Gregory Licholai
Chief Tech/Sci/R&D Officer chez ICON PUBLIC LIMITED COMPANY
Profil
Fondateur d'Immunome, Inc, Gregory P. Licholai est actuellement Chief Medical & Innovation Officer chez ICON plc et président d'Elpidera LLC. Le Dr Licholai siège également au conseil d'administration de Sollis Therapeutics, Inc. Il a précédemment occupé les postes de président et de directeur scientifique chez Castle Creek Pharmaceuticals LLC, de vice-président des affaires médicales chez Amicus Therapeutics, Inc. et de directeur des investissements et des partenariats chez Medtronic Neurological, ainsi que de directeur chez Immunome, Inc. Gregory P. Licholai a obtenu un diplôme de premier cycle au Boston College, un doctorat à l'université de Yale et un MBA à l'université de Harvard.
Postes actifs de Gregory Licholai
| Sociétés | Poste | Début |
|---|---|---|
| ICON PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | 01/11/2021 |
| Elpidera LLC | President | - |
Anciens postes connus de Gregory Licholai
| Sociétés | Poste | Fin |
|---|---|---|
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | President | 01/02/2018 |
| AMICUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 02/10/2009 |
| Medtronic Neurological | Corporate Officer/Principal | 01/11/2002 |
| MODERNA, INC. | Corporate Officer/Principal | - |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formation de Gregory Licholai
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Boston College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
| Yale School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ICON PUBLIC LIMITED COMPANY | Commercial Services |
| AMICUS THERAPEUTICS, INC. | Health Technology |
| IMMUNOME, INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
| Medtronic Neurological | |
| Elpidera LLC | |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Health Technology |
